{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:47:40Z","timestamp":1789732060901,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Topogr"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10548-018-0652-9","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T13:54:51Z","timestamp":1527602091000},"page":"886-894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Clinical Correlations of Brain Lesion Location in Multiple Sclerosis: Voxel-Based Analysis of a Large Clinical Trial Dataset"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6397-0758","authenticated-orcid":false,"given":"Anna","family":"Altermatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gaetano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Magon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter A.","family":"H\u00e4ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davorka","family":"Tomic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Wuerfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst-Wilhelm","family":"Radue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Kappos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Sprenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"key":"652_CR1","first-page":"1","volume":"2","author":"J Andersson","year":"2007","unstructured":"Andersson J, Jenkinson M, Smith S (2007) Non-linear registration aka s spatial normalisation. FMRIB Technical Report TR07JA2. FMRIB Anal Group Univ Oxford 2:1\u201321.","journal-title":"FMRIB Anal Group Univ Oxford"},{"key":"652_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00019052-200206000-00003","volume":"15","author":"F Barkhof","year":"2002","unstructured":"Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15:239\u2013245","journal-title":"Curr Opin Neurol"},{"key":"652_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nn1050","volume":"6","author":"E Bates","year":"2003","unstructured":"Bates E, Wilson SM, Saygin AP et al (2003) Voxel-based lesion\u2013symptom mapping. Nat Neurosci 6:448\u2013450. https:\/\/doi.org\/10.1038\/nn1050","journal-title":"Nat Neurosci"},{"key":"652_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1017\/S1355617711000403","volume":"17","author":"RHB Benedict","year":"2011","unstructured":"Benedict RHB, Holtzer R, Motl RW et al (2011) Upper and lower extremity motor function and cognitive impairment in multiple sclerosis. J Int Neuropsychol Soc 17:643\u2013653. https:\/\/doi.org\/10.1017\/S1355617711000403","journal-title":"J Int Neuropsychol Soc"},{"key":"652_CR5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57:289\u2013300","journal-title":"J R Stat Soc B"},{"key":"652_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ijpsycho.2005.12.008","volume":"60","author":"SL Bressler","year":"2006","unstructured":"Bressler SL, Tognoli E (2006) Operational principles of neurocognitive networks. Int J Psychophysiol 60:139\u2013148. https:\/\/doi.org\/10.1016\/j.ijpsycho.2005.12.008","journal-title":"Int J Psychophysiol"},{"key":"652_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4161\/pri.22580","volume":"7","author":"M Calabrese","year":"2013","unstructured":"Calabrese M, Favaretto A, Martini V, Gallo P (2013) Grey matter lesions in MS: from histology to clinical implications. Prion 7:20\u201327. https:\/\/doi.org\/10.4161\/pri.22580","journal-title":"Prion"},{"key":"652_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S1474-4422(14)70049-3","volume":"13","author":"PA Calabresi","year":"2014","unstructured":"Calabresi PA, Radue E-W, Goodin D et al (2014) Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Neurol 13:545\u2013556. https:\/\/doi.org\/10.1016\/S1474-4422(14)70049-3","journal-title":"Lancet Neurol"},{"key":"652_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S1053-8119(03)00117-4","volume":"19","author":"A Charil","year":"2003","unstructured":"Charil A, Zijdenbos AP, Taylor J et al (2003) Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 19:532\u2013544. https:\/\/doi.org\/10.1016\/S1053-8119(03)00117-4","journal-title":"Neuroimage"},{"key":"652_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/135245859900500409","volume":"5","author":"JS Fischer","year":"1999","unstructured":"Fischer JS, Rudick RA, Cutter GR, Reingold SC (1999) The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler J 5:244\u2013250. https:\/\/doi.org\/10.1177\/135245859900500409","journal-title":"Mult Scler J"},{"key":"652_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","volume":"18","author":"JD Fisk","year":"1994","unstructured":"Fisk JD, Ritvo PG, Ross L et al (1994) Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 18:79\u201383","journal-title":"Clin Infect Dis"},{"key":"652_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1214\/14-AOAS718","volume":"8","author":"T Ge","year":"2014","unstructured":"Ge T, M\u00fcller-Lenke N, Bendfeldt K et al (2014) Analysis of multiple sclerosis lesions via spatially varying coefficients. Ann Appl Stat 8:1095\u20131118. https:\/\/doi.org\/10.1214\/14-AOAS718","journal-title":"Ann Appl Stat"},{"key":"652_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","volume":"5","author":"M Jenkinson","year":"2001","unstructured":"Jenkinson M, Smith S (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5:143\u2013156. https:\/\/doi.org\/10.1016\/S1361-8415(01)00036-6","journal-title":"Med Image Anal"},{"key":"652_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1006\/nimg.2002.1132","volume":"17","author":"M Jenkinson","year":"2002","unstructured":"Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17:825\u2013841. https:\/\/doi.org\/10.1006\/nimg.2002.1132","journal-title":"Neuroimage"},{"key":"652_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","volume":"362","author":"L Kappos","year":"2010","unstructured":"Kappos L, Radue E-W, O\u2019Connor P et al (2010) A Placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 362:387\u2013401. https:\/\/doi.org\/10.1056\/NEJMoa0909494","journal-title":"N Engl J Med"},{"key":"652_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1177\/1352458510391342","volume":"17","author":"ZT Kincses","year":"2011","unstructured":"Kincses ZT, Ropele S, Jenkinson M et al (2011) Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis. Mult Scler 17:681\u2013689. https:\/\/doi.org\/10.1177\/1352458510391342","journal-title":"Mult Scler"},{"key":"652_CR17","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.neuroimage.2008.12.037","volume":"46","author":"A Klein","year":"2009","unstructured":"Klein A, Andersson J, Ardekani BA et al (2009) Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 46:786\u2013802. https:\/\/doi.org\/10.1016\/j.neuroimage.2008.12.037","journal-title":"Neuroimage"},{"key":"652_CR18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131453. https:\/\/doi.org\/10.1212\/WNL.33.11.1444","journal-title":"Neurology"},{"key":"652_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2202-15-106","volume":"15","author":"S Magon","year":"2014","unstructured":"Magon S, Gaetano L, Chakravarty MM et al (2014) White matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal study. BMC Neurosci 15:106-116. https:\/\/doi.org\/10.1186\/1471-2202-15-106","journal-title":"BMC Neurosci"},{"key":"652_CR20","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1098\/rstb.2001.0915","volume":"356","author":"J Mazziotta","year":"2001","unstructured":"Mazziotta J, Toga A, Evans A et al (2001) A probabilistic atlas and reference system for the human brain: international consortium for brain mapping (ICBM). Philos Trans R Soc Lond B 356:1293\u20131322. https:\/\/doi.org\/10.1098\/rstb.2001.0915","journal-title":"Philos Trans R Soc Lond B"},{"key":"652_CR21","doi-asserted-by":"publisher","first-page":"e0177727","DOI":"10.1371\/journal.pone.0177727","volume":"12","author":"D Mollison","year":"2017","unstructured":"Mollison D, Sellar R, Bastin M et al (2017) The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: a systematic review and meta-analysis. PLoS ONE 12:e0177727. https:\/\/doi.org\/10.1371\/journal.pone.0177727","journal-title":"PLoS ONE"},{"key":"652_CR22","volume-title":"MRI atlas of human white matter","author":"S Mori","year":"2005","unstructured":"Mori S, Crain BJ (2005) MRI atlas of human white matter. Elsevier, Amsterdam"},{"key":"652_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d. Ann Neurol 58:840\u2013846. https:\/\/doi.org\/10.1002\/ana.20703","journal-title":"Ann Neurol"},{"key":"652_CR24","doi-asserted-by":"publisher","first-page":"e44826","DOI":"10.1371\/journal.pone.0044826","volume":"7","author":"F Rossi","year":"2012","unstructured":"Rossi F, Giorgio A, Battaglini M et al (2012) Relevance of brain lesion location to cognition in relapsing multiple sclerosis. PLoS ONE 7:e44826. https:\/\/doi.org\/10.1371\/journal.pone.0044826","journal-title":"PLoS ONE"},{"key":"652_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1177\/1756285613484079","volume":"6","author":"A Rovira","year":"2013","unstructured":"Rovira A, Auger C, Alonso J (2013) Magnetic resonance monitoring of lesion evolution in multiple sclerosis. Ther Adv Neurol Disord 6:298\u2013310. https:\/\/doi.org\/10.1177\/1756285613484079","journal-title":"Ther Adv Neurol Disord"},{"key":"652_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/hbm.20566","volume":"30","author":"M Sdika","year":"2009","unstructured":"Sdika M, Pelletier D (2009) Nonrigid registration of multiple sclerosis brain images using lesion inpainting for morphometry or lesion mapping. Hum Brain Mapp 30:1060\u20131067. https:\/\/doi.org\/10.1002\/hbm.20566","journal-title":"Hum Brain Mapp"},{"key":"652_CR27","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.neuroimage.2008.05.038","volume":"42","author":"J Sepulcre","year":"2008","unstructured":"Sepulcre J, Masdeu JC, Sastre-Garriga J et al (2008) Mapping the brain pathways of declarative verbal memory: evidence from white matter lesions in the living human brain. Neuroimage 42:1237\u20131243. https:\/\/doi.org\/10.1016\/j.neuroimage.2008.05.038","journal-title":"Neuroimage"},{"key":"652_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.neuroimage.2009.04.054","volume":"47","author":"J Sepulcre","year":"2009","unstructured":"Sepulcre J, Masdeu JC, Pastor MA et al (2009) Brain pathways of verbal working memory. Neuroimage 47:773\u2013778. https:\/\/doi.org\/10.1016\/j.neuroimage.2009.04.054","journal-title":"Neuroimage"},{"key":"652_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","volume":"4","author":"GM Sullivan","year":"2012","unstructured":"Sullivan GM, Feinn R (2012) Using effect size-or why the P value is not enough. J Grad Med Educ 4:279\u2013282. https:\/\/doi.org\/10.4300\/JGME-D-12-00156.1","journal-title":"J Grad Med Educ"},{"key":"652_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1177\/1545968311433208","volume":"26","author":"V Tomassini","year":"2012","unstructured":"Tomassini V, Johansen-Berg H, Jbabdi S et al (2012) Relating brain damage to brain plasticity in patients with multiple sclerosis. Neurorehabil Neural Repair 26:581\u2013593. https:\/\/doi.org\/10.1177\/1545968311433208","journal-title":"Neurorehabil Neural Repair"},{"key":"652_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.acn.2005.07.006","volume":"21","author":"T Tombaugh","year":"2006","unstructured":"Tombaugh T (2006) A comprehensive review of the paced auditory serial addition test (PASAT). Arch Clin Neuropsychol 21:53\u201376. https:\/\/doi.org\/10.1016\/j.acn.2005.07.006","journal-title":"Arch Clin Neuropsychol"},{"key":"652_CR32","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/jmri.21679","volume":"29","author":"MM Vellinga","year":"2009","unstructured":"Vellinga MM, Geurts JJG, Rostrup E et al (2009) Clinical correlations of brain lesion distribution in multiple sclerosis. J Magn Reson Imaging 29:768\u2013773. https:\/\/doi.org\/10.1002\/jmri.21679","journal-title":"J Magn Reson Imaging"}],"container-title":["Brain Topography"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10548-018-0652-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10548-018-0652-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10548-018-0652-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T03:46:32Z","timestamp":1720323992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10548-018-0652-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1007\/s10548-018-0652-9","relation":{},"ISSN":["0896-0267","1573-6792"],"issn-type":[{"value":"0896-0267","type":"print"},{"value":"1573-6792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]},"assertion":[{"value":"10 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Anna Altermatt: No conflicts of interest. Laura Gaetano: Temporary employee of Novartis Pharma AG. Stefano Magon: received research support from Swiss MS Society, Swiss National Science Foundation, University of Basel and Stiftung zur F\u00f6rderung der gastroenterologischen und allgemeinen klinischen Forschung sowie der medizinischen Bildauswertung des Universit\u00e4tsspitals Basel. Dieter Haering, Davorka Tomic: Full-time employee of Novartis Pharma AG. Jens Wuerfel: is CEO of MIAC AG. He served on advisory boards for Actelion, Biogen, Genzyme, Novartis and Roche. He received research grants from Novartis, and speaker honoraria from Bayer, Biogen, Genzyme, Novartis, Teva and Biogen. JW was supported by the DFG, the EU, the German ministry of education and research (BMBF\/KKNMS) and the German ministry of economy (BMWi). Ernst-Wilhelm Radue: has received research support from Biogen Idec, Merck-Serono, Novartis and Actelion. Ludwig Kappos: Author\u2019s institution (University Hospital Basel) has received in last 3\u00a0years and used exclusively for research support: steering committee, advisory board, and consultancy fees (Actelion, Addex, Bayer HealthCare, Biogen Idec, Biotica, Genzyme, Lilly, Merck,Mitsubishi, Novartis, Ono Pharma, Pfizer, Receptos, Sanofi, Santhera, Siemens, Teva, UCB, XenoPort); speaker fees (Bayer HealthCare, Biogen Idec, Merck, Novartis, Sanofi, Teva); support of educational activities (Bayer HealthCare, Biogen, CSL Behring, Genzyme, Merck, Novartis, Sanofi, Teva); royalties (Neurostatus Systems GmbH); grants (Bayer HealthCare, Biogen Idec, European Union, Merck, Novartis, Roche Research Foundation, Swiss MS Society, Swiss National Research Foundation). Till Sprenger: has received no personal compensation. His previous and current institutions have received payments for research, for consulting and speaking activities from: Actelion, ATI, Biogen Idec, Electrocore, Sanofi Genzyme, Mitsubishi Pharma, Teva, Novartis; grants received (EFIC-Gr\u00fcnenthal, Novartis Pharmaceuticals Switzerland, Swiss MS Society, Swiss National Research Foundation).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}